🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

28 recruiting trials

for Endometrial Cancer Stage III

European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III NCT04504006n/a1 site📍 Essen Dr. Paul Buderath · Tests: Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL) A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer NCT05691010EARLY Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Intensity-modulated radiation therapy, Carboplatin, Paclitaxel Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer NCT06712472Phase 315 sites📍 Albi📍 Angers📍 Besançon Gustave Roussy, Cancer Campus, Grand Paris · Tests: Olaparib (300 mg BID) Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer NCT07198074Phase 3304 sites📍 Birmingham📍 Anchorage📍 Phoenix National Cancer Institute (NCI) · Tests: Bevacizumab, Biospecimen Collection, Carboplatin, Computed Tomography, Magnetic Resonance Imaging Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Tissue Collection MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer NCT07584161NA1 site📍 Beijing Xiaorong Hou · Tests: Moderately fractionated radiotherapy using online adaptive radiotherapy technology, Conventionally fractionated radioth… Prehabilitation in Gynaecological Cancer Patients NCT04789694Phase 31 site📍 Prague Charles University, Czech Republic · Tests: Physiological intervention, Psychological intervention, Nutritional intervention PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer NCT03621904n/a1 site📍 Nijmegen Radboud University Medical Center · Tests: Hormonal Antineoplastics Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial NCT05564377Phase 2484 sites📍 Birmingham📍 Mobile📍 Anchorage National Cancer Institute (NCI) · Tests: Alpelisib, Binimetinib, Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer NCT06989112Phase 3257 sites📍 Tucson📍 Little Rock📍 Duarte AstraZeneca · Tests: Trastuzumab deruxtecan, Rilvegostomig, Pembrolizumab, Carboplatin, Paclitaxel ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer NCT07270666NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: ctDNA Testing, Blood draw, Surveys, Semi-structured interviews Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer NCT06584032Phase 317 sites📍 Beijing📍 Chongqing📍 Fuzhou Hutchmed · Tests: fruquintinib, sintilimab, paclitaxel, doxorubicin IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Molecular and ctDNA Characterization of High-Risk Endometrial Cancer NCT07062016n/a1 site📍 Rochester Mayo Clinic · Tests: Non-Interventional Study Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy NCT04997096NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: Exercise, Attention Control Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers NCT04891029NA2 sites📍 Montreal📍 Montreal McGill University · Tests: DOvEEgene test Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer NCT05646316Phase 360 sites📍 Washington D.C.📍 Coral Gables📍 Deerfield Beach NRG Oncology · Tests: Biospecimen Collection, Diagnostic Imaging Testing, Excisional Biopsy, Indocyanine Green Solution, Minimally Invasive S… An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study NCT06855706NA1 site📍 Buffalo Roswell Park Cancer Institute · Tests: Behavioral Intervention, Best Practice, Biospecimen Collection, Electronic Health Record Review, Exercise Intervention Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for Endometrial Cancer (PURE-cohort) NCT07779109NA1 site📍 Zaragoza Instituto de Investigación Sanitaria Aragón · Tests: Ultra-hypofractionation schedule of 27.5Gy in 5 fractions on image-guided adjuvant pelvic IMRT/VMAT radiotherapy Sentinel Node Biopsy in Endometrial Cancer NCT04073706Phase 323 sites📍 Houston📍 Buenos Aires📍 Buenos Aires Queensland Centre for Gynaecological Cancer · Tests: TH BSO with SNB Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wis… A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer NCT06340568Phase 3206 sites📍 Los Angeles📍 Aurora📍 New Haven BioNTech SE · Tests: BNT323/DB-1303, Doxorubicin, Paclitaxel, Docetaxel A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer NCT07741968NA11 sites📍 Arcadia📍 Duarte📍 Huntington Beach City of Hope Medical Center · Tests: Best Practice, Interview, Supportive Care, Supportive Care, Supportive Care Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381Phase 1, Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab, Sargramostim, Biospecimen Collection Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer NCT05819892Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Paclitaxel, Carboplatin, Dostarlimab, Cisplatin PROfiling Based Endometrial Cancer Adjuvant Therapy NCT05179447NA10 sites📍 Wuhan📍 Jinan📍 Hangzhou Women's Hospital School Of Medicine Zhejiang University · Tests: Vaginal brachytherapy, External beam radiotherapy, Observation, Chemoradiation therapy HB0025-C-0301: A Study to Investigate HB0025 Combined With Chemotherapy as First-Line Treatment for Advanced or Recurrent MMR-proficient Endometrial Cancer NCT07902999Phase 32 sites📍 Guangzhou📍 Shenyang Shanghai Huaota Biopharmaceutical Co., Ltd. · Tests: HB0025 Injection, Paclitaxel injection, Carboplatin injection, Placebo matching HB0025 Vaginal Cuff Brachytherapy Fractionation Study NCT03785288Phase 33 sites📍 Baltimore📍 Syracuse📍 Charlottesville Kara Romano, MD · Tests: HDR vaginal brachytherapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy